GSOR11   Presentation Time: 12:50 PM

Endometrial cancer (EC) is the fourth most prevalent malignancy in females, and the leading gynecologic cancer [1]. Although the incidence of EC is 33% lower in Black women, they are 41% more likely to present with advanced stage disease and have an 80% higher mortality [2, 3]. Standard of care for EC includes total vaginal hysterectomy +/- adjuvant chemotherapy or radiation therapy (RT) [4]. These treatments are associated with side effects such as vaginal stenosis or shortening, which could be improved with vaginal dilator use [4].
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research